Privia Health Group, Inc. (PRVA)
Automate Your Wheel Strategy on PRVA
With Tiblio's Option Bot, you can configure your own wheel strategy including PRVA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRVA
- Rev/Share 14.9328
- Book/Share 5.8821
- PB 4.2017
- Debt/Equity 0.0082
- CurrentRatio 1.8829
- ROIC 0.0186
- MktCap 2800502400.0
- FreeCF/Share 1.0227
- PFCF 22.7011
- PE 177.3719
- Debt/Assets 0.0046
- DivYield 0
- ROE 0.0249
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 4
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Initiation | PRVA | Needham | -- | Buy | -- | $25 | Jan. 10, 2025 |
Initiation | PRVA | Macquarie | -- | Outperform | -- | -- | Dec. 16, 2024 |
Initiation | PRVA | KeyBanc Capital Markets | -- | Overweight | -- | $23 | Oct. 11, 2024 |
News
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Privia Health (PRVA) Misses Q1 Earnings Estimates
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Read More
Privia Health Reports First Quarter 2025 Financial Results
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025.
Read More
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024.
Read More
About Privia Health Group, Inc. (PRVA)
- IPO Date 2021-04-28
- Website https://www.priviahealth.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Parth Mehrotra
- Employees 1140